vvos news - Search News

Why Vivos Therapeutics (VVOS) Stock Is Down 25% Today

Vivos Therapeutics shares are trading lower by 25% Thursday morning. The company announced a $4.3 million registered offering.

bovnews · 8h

Vivos Therapeutics Inc (VVOS) Stock: More Resilient Than It Appears

In recent trading, Vivos Therapeutics Inc (VVOS) stock price has shown some volatility, fluctuating 4.41% over the last five trades and 8.57% over the past 30 trades. This represents a notable shift from earlier in the year.

Hosted on MSN · 2d

TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces $4.3M Registered Direct Offering

Vivos Therapeutics (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (“OSA”) in adults),

Business Insider · 2d

Vivos Therapeutics Offers Of 1.363 Mln Shares At $3.15/share, Pre-Market Stock Down

Vivos Therapeutics, Inc. (VVOS), a medical device and technology company, announced on Thursday that it has inked a deal with

MarketWatch · 2d

Vivos Therapeutics Shares Drop 27% After Pricing of Common Stock Offering

Vivos Therapeutics shares dropped Thursday after the company said it is offering 1.4 million common shares at $3.15 per share in a registered direct offering. Shares were down 27% to $3.03 in recent trading after closing at $4.

Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children

On Wednesday, the FDA granted 510(k) clearance to Vivos Therapeutics, Inc.’s (NASDAQ:VVOS) flagship oral medical device, ...

3don MSN

Vivos surges on FDA nod for pediatric sleep apnea device

Vivos Therapeutics (VVOS) stock gains as company receives FDA clearance for its DNA appliance to treat obstructive sleep ...

bovnews3d

Vivos Therapeutics (VVOS) Surges Following Landmark FDA Approval

Vivos Therapeutics is a pioneering medical device and technology company focused on addressing sleep-related breathing disorders (SRBDs), particularly obstructive sleep apnea (OSA). Their flagship ...

3don MSN

FDA Approval Sends Shares of this Healthcare Company Higher

What a session it was for a certain Colorado-based %Healthcare company after it was announced that it received the US Food ...

Benzinga.com2d

Vivos Therapeutics (NASDAQ:VVOS) Stock, Short Interest Report

Short interest in Vivos Therapeutics Inc (NASDAQ:VVOS) decreased during the last reporting period, falling from 58.82K to 56.53K. This put 2.28% of the company's publicly available shares short.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results